Nomura Research Institute, Ltd.
NRILY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $134,161,000 | $79,643,000 | $76,307,000 | $71,445,000 |
| Dep. & Amort. | $48,910,000 | $48,157,000 | $45,092,000 | $41,941,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$13,613,000 | -$3,277,000 | $7,682,000 | -$26,043,000 |
| Other Non-Cash | -$39,262,000 | $17,754,000 | -$10,182,000 | $10,794,000 |
| Operating Cash Flow | $130,196,000 | $142,277,000 | $118,899,000 | $98,137,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$6,660,000 | -$7,484,000 | -$54,701,000 | -$42,977,000 |
| Net Acquisitions | -$615,000 | -$4,071,000 | -$1,873,000 | -$64,725,000 |
| Inv. Purchases | -$5,324,000 | -$1,999,000 | -$9,418,000 | -$8,262,000 |
| Inv. Sales/Matur. | $8,317,000 | $2,073,000 | $5,386,000 | $2,101,000 |
| Other Inv. Act. | -$43,308,000 | -$41,941,000 | -$584,000 | -$16,684,000 |
| Investing Cash Flow | -$47,590,000 | -$53,422,000 | -$61,190,000 | -$130,547,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$20,129,000 | $55,812,000 | -$9,669,000 | $81,498,000 |
| Stock Issued | $8,285,000 | $5,034,000 | $22,722,000 | $6,750,000 |
| Stock Repurch. | -$30,306,000 | -$68,427,000 | -$20,156,000 | -$60,136,000 |
| Dividends Paid | -$33,313,000 | -$27,583,000 | -$25,372,000 | -$22,647,000 |
| Other Fin. Act. | -$11,851,000 | -$12,411,000 | -$12,446,000 | -$13,460,000 |
| Financing Cash Flow | -$87,314,000 | -$47,575,000 | -$44,921,000 | -$7,995,000 |
| Forex Effect | -$629,000 | $3,399,000 | $859,000 | $2,829,000 |
| Net Chg. in Cash | -$5,338,000 | $44,678,000 | $13,647,000 | -$37,577,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $173,935,000 | $129,257,000 | $115,610,000 | $153,187,000 |
| End Cash | $168,597,000 | $173,935,000 | $129,257,000 | $115,610,000 |
| Free Cash Flow | $80,594,000 | $92,480,000 | $64,198,000 | $55,160,000 |